NDV-3

· NovaDigm Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NDV-3, covering 2012-05-22 to 2012-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida [Phase 1]